Literature DB >> 10522059

Gastric exclusion for unresectable gastric cancer.

Y Nakata1, K Kimura, N Tomioka, M Sato, Y Watanabe, K Kawachi.   

Abstract

BACKGROUND/AIMS: Conventional gastrojejunostomy is sometimes performed for unresectable gastric cancer, but it is not fully effective. To improve the patient's quality of life, we performed gastric exclusion.
METHODOLOGY: Twenty-seven patients who received gastrojejunostomy (11 conventional, 16 gastric exclusion) were retrospectively examined as to post-operative quality of life and outcome.
RESULTS: No stomal strictures were observed, and gastrointestinal bleeding was significantly reduced in the gastric exclusion group. These advantages enabled the gastric exclusion group to achieve better quality of life, as indicated by longer oral intake (244 days vs. 98 days) and home stay (211 days vs. 91 days). The prognosis also improved. The 50% survival period in the gastric exclusion group was 229 days, whereas, that of the conventional gastrojejunostomy group was 131 days.
CONCLUSIONS: The quality of life and prognosis of the gastric exclusion group significantly improved, and we believe that the improvement of the quality of life yielded a better prognosis. We recommend gastric exclusion as a standard procedure for unresectable gastric cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10522059

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Gastrojejunostomy as induction treatment for S-1-based chemotherapy in patients with incurable gastric cancer.

Authors:  Manabu Ohashi; Tatsuo Kanda; Masaki Hirota; Takashi Kobayashi; Kazuhito Yajima; Shin-ichi Kosugi; Katsuyoshi Hatakeyama
Journal:  Surg Today       Date:  2008-11-28       Impact factor: 2.549

Review 2.  A systematic review and meta-analysis comparing partial stomach partitioning gastrojejunostomy versus conventional gastrojejunostomy for malignant gastroduodenal obstruction.

Authors:  Koshi Kumagai; Ioannis Rouvelas; Annika Ernberg; Saga Persson; Apostolos Analatos; Daniela Mariosa; Mats Lindblad; Magnus Nilsson; Weimin Ye; Lars Lundell; Jon A Tsai
Journal:  Langenbecks Arch Surg       Date:  2016-06-23       Impact factor: 3.445

3.  Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation.

Authors:  Erik Johnsson; Anders Thune; Bengt Liedman
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

4.  Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis.

Authors:  Dionigi Lorusso; Aurore Giliberti; Margherita Bianco; Giulio Lantone; Gioacchino Leandro
Journal:  J Gastrointest Oncol       Date:  2019-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.